Certified Advisory Corp Abb Vie Inc. Transaction History

Certified Advisory Corp

$882 Million
Q3 2024

A detailed history of Certified Advisory Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Certified Advisory Corp holds 7,436 shares of ABBV stock, worth $1.32 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

7,436

Previous 7,504 0.91%

Holding current value

$1.32 Million

Previous $1.29 Million 14.06%

% of portfolio

0.17%

Previous 0.17%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $11,141 - $13,554	-68 Reduced 0.91%	7,436 $1.47 Million
Q2 2024 Aug 13, 2024	SELL	$154.79 - $180.76 $61,606 - $71,942	-398 Reduced 5.04%	7,504 $1.29 Million
Q1 2024 May 10, 2024	BUY	$159.82 - $182.1 $87,101 - $99,244	545 Added 7.41%	7,902 $1.44 Million
Q4 2023 Feb 09, 2024	BUY	$137.6 - $154.97 $3,302 - $3,719	24 Added 0.33%	7,357 $1.14 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $1,068 - $1,237	-8 Reduced 0.11%	7,333 $1.09 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $68,640 - $85,418	518 Added 7.59%	7,341 $989,000
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $59,000 - $67,948	408 Added 6.36%	6,823 $1.09 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $26,970 - $32,344	-195 Reduced 2.95%	6,415 $1.04 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $5,905 - $6,772	44 Added 0.67%	6,610 $887,000
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $8,807 - $11,197	64 Added 0.98%	6,566 $1.01 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $3,959 - $4,912	30 Added 0.46%	6,502 $1.06 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $3,652 - $4,621	34 Added 0.53%	6,472 $876,000
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $106 - $120	-1 Reduced 0.02%	6,438 $694,000
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $5,050 - $5,626	-48 Reduced 0.74%	6,439 $725,000
Q1 2021 May 10, 2021	SELL	$102.3 - $112.62 $1,943 - $2,139	-19 Reduced 0.29%	6,487 $702,000
Q2 2020 Jul 27, 2020	BUY	$73.37 - $98.18 $116,805 - $156,302	1,592 Added 32.4%	6,506 $639,000
Q1 2020 Apr 27, 2020	BUY	$64.5 - $97.79 $6,772 - $10,267	105 Added 2.18%	4,914 $375,000
Q4 2019 Jan 29, 2020	SELL	$72.13 - $90.25 $62,753 - $78,517	-870 Reduced 15.32%	4,809 $426,000
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $21,098 - $25,366	-335 Reduced 5.57%	5,679 $430,000
Q2 2019 Aug 07, 2019	BUY	$65.7 - $83.98 $8,475 - $10,833	129 Added 2.19%	6,014 $438,000
Q1 2019 May 07, 2019	BUY	$77.14 - $90.79 $40,652 - $47,846	527 Added 9.84%	5,885 $475,000
Q4 2018 Feb 04, 2019	BUY	$77.85 - $96.01 $22,887 - $28,226	294 Added 5.81%	5,358 $494,000
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $4,712 - $5,238	-53 Reduced 1.04%	5,064 $479,000
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $10,773 - $12,747	120 Added 2.4%	5,117 $474,000
Q1 2018 Apr 30, 2018	BUY	$92.01 - $123.21 $38,092 - $51,008	414 Added 9.03%	4,997 $472,000
Q4 2017 Feb 22, 2018	BUY	$89.56 - $98.21 $410,453 - $450,096	4,583	4,583 $442,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Certified Advisory Corp, based on Form 13F filings with the SEC.

News

Stay updated on Certified Advisory Corp with notifications on news.

Account

Certified Advisory Corp Abb Vie Inc. Transaction History